[1]
Phùng, L.T. et al. 2024. COST-UTILITY ANALYSIS OF EMPAGLIFLOZIN IN TREATMENT FOR TYPE-2 DIABETES MELLITUS IN VIETNAM.
Vietnam Medical Journal
. 540, 2 (Jul. 2024). DOI:https://doi.org/10.51298/vmj.v540i2.10425.